Cladribine regimen for treating multiple sclerosis

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/21 (2006.01) A61K 9/00 (2006.01) A61K 31/7056 (2006.01) A61P 37/06 (2006.01)

Patent

CA 2649810

The present invention relates to the use of multiple doses of Cladribine combined with beta interferon for the treatment of multiple sclerosis in patients who are refractory to at least one conventional therapy.

La présente invention concerne l'utilisation de multiples doses de Cladribine combinées à l'interféron bêta pour le traitement de la sclérose en plaques chez les patients qui sont réfractaires à au moins une thérapie conventionnelle.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Cladribine regimen for treating multiple sclerosis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cladribine regimen for treating multiple sclerosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cladribine regimen for treating multiple sclerosis will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1761992

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.